PT1812581E - Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica - Google Patents

Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica Download PDF

Info

Publication number
PT1812581E
PT1812581E PT05826088T PT05826088T PT1812581E PT 1812581 E PT1812581 E PT 1812581E PT 05826088 T PT05826088 T PT 05826088T PT 05826088 T PT05826088 T PT 05826088T PT 1812581 E PT1812581 E PT 1812581E
Authority
PT
Portugal
Prior art keywords
lactams
candida antarctica
preparation
optically active
optical resolution
Prior art date
Application number
PT05826088T
Other languages
English (en)
Portuguese (pt)
Inventor
Ankush Argade
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of PT1812581E publication Critical patent/PT1812581E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT05826088T 2004-11-15 2005-11-15 Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica PT1812581E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62840104P 2004-11-15 2004-11-15

Publications (1)

Publication Number Publication Date
PT1812581E true PT1812581E (pt) 2009-04-22

Family

ID=36190809

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05826088T PT1812581E (pt) 2004-11-15 2005-11-15 Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica

Country Status (10)

Country Link
US (1) US7459301B2 (https=)
EP (1) EP1812581B1 (https=)
JP (1) JP4738416B2 (https=)
AT (1) ATE421996T1 (https=)
CA (1) CA2580151C (https=)
DE (1) DE602005012597D1 (https=)
DK (1) DK1812581T3 (https=)
ES (1) ES2320364T3 (https=)
PT (1) PT1812581E (https=)
WO (1) WO2006055528A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1763514A2 (en) * 2004-05-18 2007-03-21 Rigel Pharmaceuticals, Inc. Cycloalkyl substituted pyrimidinediamine compounds and their uses
GB2420559B (en) * 2004-11-15 2008-08-06 Rigel Pharmaceuticals Inc Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
JP5400388B2 (ja) 2005-12-15 2014-01-29 ライジェル ファーマシューティカルズ, インコーポレイテッド キナーゼインヒビターおよびその利用
HU227663B1 (en) * 2007-07-09 2011-10-28 Univ Szegedi Resolution process
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
EP3076963A4 (en) 2013-12-06 2017-09-13 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-cd30 antibodies
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与
US11874276B2 (en) 2018-04-05 2024-01-16 Dana-Farber Cancer Institute, Inc. STING levels as a biomarker for cancer immunotherapy
WO2019201279A1 (zh) * 2018-04-18 2019-10-24 广东东阳光药业有限公司 一种桥环化合物的制备方法
US20220305048A1 (en) 2019-08-26 2022-09-29 Dana-Farber Cancer Institute, Inc. Use of heparin to promote type 1 interferon signaling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002520027A (ja) * 1998-07-09 2002-07-09 ロンザ ア−ゲ− (1r,4s)−2−アザビシクロ[2.2.1]ヘプタ−5−エン−3−オン誘導体の製造方法

Also Published As

Publication number Publication date
EP1812581B1 (en) 2009-01-28
DK1812581T3 (da) 2009-05-11
CA2580151A1 (en) 2006-05-26
JP2008520206A (ja) 2008-06-19
ES2320364T3 (es) 2009-05-21
JP4738416B2 (ja) 2011-08-03
US20060166308A1 (en) 2006-07-27
WO2006055528A2 (en) 2006-05-26
CA2580151C (en) 2014-02-04
DE602005012597D1 (de) 2009-03-19
EP1812581A2 (en) 2007-08-01
ATE421996T1 (de) 2009-02-15
WO2006055528A3 (en) 2006-08-31
US7459301B2 (en) 2008-12-02

Similar Documents

Publication Publication Date Title
Busto et al. Hydrolases in the stereoselective synthesis of N-heterocyclic amines and amino acid derivatives
Margolin Enzymes in the synthesis of chiral drugs
Bezborodov et al. Enzymatic biocatalysis in chemical synthesis of pharmaceuticals
Patel Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances
PT1812581E (pt) Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica
Gotor Biocatalysis applied to the preparation of pharmaceuticals
Gotor Non-conventional hydrolase chemistry: amide and carbamate bond formation catalyzed by lipases
Miyazawa Enzymatic resolution of amino acids via ester hydrolysis
WO2003022785A3 (en) Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
WO2006133079A3 (en) Increasing perhydrolase activity in esterases and/or lipases
ATE417100T1 (de) Eine verbesserte immobilisierte penicillin g acylase
DE69914458D1 (de) Verfahren zur enzymatischen auflösung von laktamen
Gill et al. Biocatalytic ammonolysis of (5S)-4, 5-dihydro-1H-pyrrole-1, 5-dicarboxylic acid, 1-(1, 1-dimethylethyl)-5-ethyl ester: Preparation of an intermediate to the dipeptidyl peptidase IV inhibitor Saxagliptin
DE602004024686D1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
DK0649907T3 (da) Enzymatisk hydroxyleringsproces til fremstilling af HMG-CoA-reduktaseinhibitorer og mellemprodukter derfor
AU3170597A (en) Process for the preparation of amino alcohols and derivatives thereof
AU2002316575A1 (en) Microorganisms and processes for enhanced production of pantothenate
EP0896057A3 (en) D-aminoacylase
EP1559789A3 (en) Method for producing dipeptide
DK0602740T3 (da) Fremgangsmåde til enzymatisk fremstilling af optisk aktive transglycidsyreestere
Lundell et al. Enantiomers of adrenaline-type amino alcohols by Burkholderia cepacia lipase-catalyzed asymmetric acylation
WO2003066871A3 (en) Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds
US7125692B2 (en) Process for producing monomer
Patel Biocatalytic routes to chiral intermediates for development of drugs
Ohshiro et al. Novel L-specific cleavage of the urethane bond of t-butoxycarbonylamino acids by whole cells of Corynebacterium aquaticum